These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 24339138)
1. Genetic susceptibility for bipolar disorder and response to antidepressants in major depressive disorder. Tansey KE; Guipponi M; Domenici E; Lewis G; Malafosse A; O'Donovan M; Wendland JR; Lewis CM; McGuffin P; Uher R Am J Med Genet B Neuropsychiatr Genet; 2014 Jan; 165B(1):77-83. PubMed ID: 24339138 [TBL] [Abstract][Full Text] [Related]
2. Investigating the genetic variation underlying episodicity in major depressive disorder: suggestive evidence for a bipolar contribution. Ferentinos P; Rivera M; Ising M; Spain SL; Cohen-Woods S; Butler AW; Craddock N; Owen MJ; Korszun A; Jones L; Jones I; Gill M; Rice JP; Maier W; Mors O; Rietschel M; Lucae S; Binder EB; Preisig M; Tozzi F; Muglia P; Breen G; Craig IW; Farmer AE; Müller-Myhsok B; McGuffin P; Lewis CM J Affect Disord; 2014 Feb; 155():81-9. PubMed ID: 24215895 [TBL] [Abstract][Full Text] [Related]
3. Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Guo W; Machado-Vieira R; Mathew S; Murrough JW; Charney DS; Grunebaum M; Oquendo MA; Kadriu B; Akula N; Henter I; Yuan P; Merikangas K; Drevets W; Furey M; Mann JJ; McMahon FJ; Zarate CA; Shugart YY Transl Psychiatry; 2018 Dec; 8(1):280. PubMed ID: 30552317 [TBL] [Abstract][Full Text] [Related]
4. Genetic predictors of response to serotonergic and noradrenergic antidepressants in major depressive disorder: a genome-wide analysis of individual-level data and a meta-analysis. Tansey KE; Guipponi M; Perroud N; Bondolfi G; Domenici E; Evans D; Hall SK; Hauser J; Henigsberg N; Hu X; Jerman B; Maier W; Mors O; O'Donovan M; Peters TJ; Placentino A; Rietschel M; Souery D; Aitchison KJ; Craig I; Farmer A; Wendland JR; Malafosse A; Holmans P; Lewis G; Lewis CM; Stensbøl TB; Kapur S; McGuffin P; Uher R PLoS Med; 2012; 9(10):e1001326. PubMed ID: 23091423 [TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomic overlap between antidepressant treatment response in major depression & antidepressant associated treatment emergent mania in bipolar disorder. Nuñez NA; Coombes BJ; Beaupre LM; Ozerdem A; Resendez MG; Romo-Nava F; Bond DJ; Veldic M; Singh B; Moore KM; Betcher HK; Kung S; Prieto ML; Fuentes M; Ercis M; Miola A; Sanchez Ruiz JA; Jenkins G; Batzler A; Leung JG; Cuellar-Barboza A; Tye SJ; McElroy SL; Biernacka JM; Frye MA Transl Psychiatry; 2024 Feb; 14(1):93. PubMed ID: 38351009 [TBL] [Abstract][Full Text] [Related]
7. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder. Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920 [TBL] [Abstract][Full Text] [Related]
8. Bipolar polygenic loading and bipolar spectrum features in major depressive disorder. Wiste A; Robinson EB; Milaneschi Y; Meier S; Ripke S; Clements CC; Fitzmaurice GM; Rietschel M; Penninx BW; Smoller JW; Perlis RH Bipolar Disord; 2014 Sep; 16(6):608-16. PubMed ID: 24725193 [TBL] [Abstract][Full Text] [Related]
9. Are treatment emergent suicidality and decreased response to antidepressants in younger patients due to bipolar disorder being misdiagnosed as unipolar depression? Berk M; Dodd S Med Hypotheses; 2005; 65(1):39-43. PubMed ID: 15893115 [TBL] [Abstract][Full Text] [Related]
10. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder. Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205 [TBL] [Abstract][Full Text] [Related]
11. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder. Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572 [TBL] [Abstract][Full Text] [Related]
12. Association between the so-called "activation syndrome" and bipolar II disorder, a related disorder, and bipolar suggestive features in outpatients with depression. Takeshima M; Oka T J Affect Disord; 2013 Oct; 151(1):196-202. PubMed ID: 23790740 [TBL] [Abstract][Full Text] [Related]
13. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis. Perugi G; Pacchiarotti I; Mainardi C; Verdolini N; Menculini G; Barbuti M; Angst J; Azorin JM; Bowden CL; Mosolov S; Young AH; Vieta E; Eur Neuropsychopharmacol; 2019 Jul; 29(7):825-834. PubMed ID: 31227264 [TBL] [Abstract][Full Text] [Related]
14. Impact of genetic, sociodemographic, and clinical features on antidepressant treatment trajectories in the perinatal period. Liu X; Trinh NT; Wray NR; Lupattelli A; Albiñana C; Agerbo E; Vilhjálmsson BJ; Bergink V; Munk-Olsen T Eur Neuropsychopharmacol; 2024 Apr; 81():20-27. PubMed ID: 38310717 [TBL] [Abstract][Full Text] [Related]
15. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder. Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359 [TBL] [Abstract][Full Text] [Related]
16. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy. Akiskal HS; Benazzi F; Perugi G; Rihmer Z J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694 [TBL] [Abstract][Full Text] [Related]
17. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder. Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441 [TBL] [Abstract][Full Text] [Related]
18. A meta-analysis of polygenic risk scores for mood disorders, neuroticism, and schizophrenia in antidepressant response. Fanelli G; Domschke K; Minelli A; Gennarelli M; Martini P; Bortolomasi M; Maron E; Squassina A; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; De Ronchi D; Baune BT; ; Serretti A; Fabbri C Eur Neuropsychopharmacol; 2022 Feb; 55():86-95. PubMed ID: 34844152 [TBL] [Abstract][Full Text] [Related]
19. Association between antidepressant resistance in unipolar depression and subsequent bipolar disorder: cohort study. Li CT; Bai YM; Huang YL; Chen YS; Chen TJ; Cheng JY; Su TP Br J Psychiatry; 2012 Jan; 200(1):45-51. PubMed ID: 22016435 [TBL] [Abstract][Full Text] [Related]
20. [Depressive onset episode of bipolar disorder: clinical and prognostic considerations]. Besnier N; Fakra E; Kaladjian A; Adida M; Maurel M; Azorin JM Encephale; 2010 Jan; 36 Suppl 1():S18-22. PubMed ID: 20141803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]